| Abram Agayby, | |
|
289 County St, Attleboro, MA 02703-3512 | |
| (508) 222-7620 | |
| Not Available |
| Full Name | Abram Agayby |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 289 County St, Attleboro, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134888779 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PH237760 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Abram Agayby, 289 County St, Attleboro, MA 02703-3512 Ph: (508) 222-7620 | Abram Agayby, 289 County St, Attleboro, MA 02703-3512 Ph: (508) 222-7620 |
News Archive
Aeterna Zentaris Inc. today announced that the U.S. Food and Drug Administration has accepted for filing the Company's New Drug Application for its ghrelin agonist, macimorelin acetate, in Adult Growth Hormone Deficiency. The acceptance for filing of the NDA indicates the FDA has determined that the application is sufficiently complete to permit a substantive review.
Wal-Mart gave lawmakers a concise lesson in economics Tuesday when it disclosed that it would no longer offer health insurance to yet more of its part-time employees. ... I'll just argue that what we're seeing is the entirely predictable result of the employer mandate in the 2010 Patient Protection and Affordable Care Act - a mandate, by the way, that Wal-Mart lobbied for. The company was offering health benefits for most employees at the time, and may simply have been trying to force its competitors to do the same (Jon Healey, 10/7).
Older people who regularly exercise at a moderate to intense level may be less likely to develop the small brain lesions, sometimes referred to as "silent strokes," that are the first sign of cerebrovascular disease, according to a new study published in the June 8, 2011, online issue of Neurology, the medical journal of the American Academy of Neurology.
PositiveID Corporation announced today that it has completed development of the initial prototype of its iGlucose system, creating a small cradle that connects to any data-capable glucose meter to automatically communicate a diabetic's blood sugar readings to the iGlucose online database.
Extending hepatitis C treatment for liver transplant patients beyond current standards results in high clearance rates of the hepatitis C virus from the blood, and a low relapse rate, according to a study by Henry Ford Hospital.
› Verified 7 days ago
Aimee L Tague, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 196 Pleasant St, Attleboro, MA 02703 Phone: 508-222-7779 Fax: 508-222-0573 | |
Lori-ann Ucci, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 486 Pleasant St, Attleboro, MA 02703 Phone: 508-222-6020 | |
Dr. Edmond Michael Nunes, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 211 Park St, Attleboro, MA 02703 Phone: 508-236-7650 Fax: 508-236-8825 | |
Andrew Wayland, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 May St, Attleboro, MA 02703 Phone: 508-838-2293 Fax: 508-838-2294 | |
Sam Talala, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 196 Pleasant St, Attleboro, MA 02703 Phone: 508-222-7779 | |
Mr. Gerald Burnham, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12 Sully Ln, Attleboro, MA 02703 Phone: 401-793-3040 |